Terms: = Liver cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Treatment
20 results:
1. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
2. Risk Factors for Lenvatinib-Induced High-Grade Hypothyroidism in Patients with Hepatocellular Carcinoma: A Retrospective Study.
Uekusa S; Nemoto M; Hanai Y; Nakashin M; Miyagawa A; Yanagino S; Arita Y; Matsumoto T; Nishizawa K; Nagai H; Higai K; Matsuo K
Pharmacology; 2023; 108(5):460-468. PubMed ID: 37591220
[TBL] [Abstract] [Full Text] [Related]
3. Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression.
Yu M; Huang L; Zhang S; Jiang L; Jin Y; Gu M; Liao J; Zhang J
Front Cell Infect Microbiol; 2023; 13():1082390. PubMed ID: 36761898
[TBL] [Abstract] [Full Text] [Related]
4. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.
Tao Z; Cui Y; Xu X; Han T
Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2208844119. PubMed ID: 36179047
[TBL] [Abstract] [Full Text] [Related]
5. Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Tomczak A; Springfeld C; Dill MT; Chang DH; Kazdal D; Wagner U; Mehrabi A; Brockschmidt A; Luedde T; Naumann P; Stenzinger A; Schirmacher P; Longerich T
Br J Cancer; 2022 Nov; 127(9):1701-1708. PubMed ID: 35986087
[TBL] [Abstract] [Full Text] [Related]
6. Molecular docking and dynamic simulations of
Sangeetha R; Arockia Jeya Yasmi Prabha E; Lakshmi A; Sangavi P; Langeswaran K
J Biomol Struct Dyn; 2022; 40(24):13997-14012. PubMed ID: 34738880
[TBL] [Abstract] [Full Text] [Related]
7. Erdafitinib as a Novel and Advanced treatment Strategy of Metastatic Urothelial Carcinoma.
Bansal P; Dwivedi DK; Hatwal D; Sharma P; Gupta V; Goyal S; Maithani M
Anticancer Agents Med Chem; 2021; 21(18):2478-2486. PubMed ID: 33475078
[TBL] [Abstract] [Full Text] [Related]
8. fgfr3
Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
[TBL] [Abstract] [Full Text] [Related]
9. A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
Yamano T; Kubo S; Tomita N
Cancer Med; 2020 May; 9(10):3337-3343. PubMed ID: 32168428
[TBL] [Abstract] [Full Text] [Related]
10. treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study.
Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X
J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699
[TBL] [Abstract] [Full Text] [Related]
11. Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial Carcinoma.
McGregor BA; Sonpavde G
Expert Opin Investig Drugs; 2019 Oct; 28(10):821-826. PubMed ID: 31526130
[No Abstract] [Full Text] [Related]
12. FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the treatment of FGF19-Driven Hepatocellular cancer.
Weiss A; Adler F; Buhles A; Stamm C; Fairhurst RA; Kiffe M; Sterker D; Centeleghe M; Wartmann M; Kinyamu-Akunda J; Schadt HS; Couttet P; Wolf A; Wang Y; Barzaghi-Rinaudo P; Murakami M; Kauffmann A; Knoepfel T; Buschmann N; Leblanc C; Mah R; Furet P; Blank J; Hofmann F; Sellers WR; Graus Porta D
Mol Cancer Ther; 2019 Dec; 18(12):2194-2206. PubMed ID: 31409633
[TBL] [Abstract] [Full Text] [Related]
13. Erdafitinib: First Global Approval.
Markham A
Drugs; 2019 Jun; 79(9):1017-1021. PubMed ID: 31161538
[TBL] [Abstract] [Full Text] [Related]
14. Long Noncoding RNA fgfr3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway.
Zhuang J; He S; Wang G; Wang G; Ni J; Zhang S; Ye Y; Xia W
Oncol Res; 2018 Sep; 26(8):1257-1265. PubMed ID: 29463348
[TBL] [Abstract] [Full Text] [Related]
15. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
[TBL] [Abstract] [Full Text] [Related]
16. Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.
Kogita A; Yoshioka Y; Sakai K; Togashi Y; Sogabe S; Nakai T; Okuno K; Nishio K
Biochem Biophys Res Commun; 2015 Feb; 458(1):52-6. PubMed ID: 25623536
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo.
Chen CH; Chen MC; Wang JC; Tsai AC; Chen CS; Liou JP; Pan SL; Teng CM
Clin Cancer Res; 2014 Mar; 20(5):1274-1287. PubMed ID: 24520095
[TBL] [Abstract] [Full Text] [Related]
18. treatment of refractory chronic GVHD with rituximab: a GITMO study.
Zaja F; Bacigalupo A; Patriarca F; Stanzani M; Van Lint MT; Filì C; Scimè R; Milone G; Falda M; Vener C; Laszlo D; Alessandrino PE; Narni F; Sica S; Olivieri A; Sperotto A; Bosi A; Bonifazi F; Fanin R;
Bone Marrow Transplant; 2007 Aug; 40(3):273-7. PubMed ID: 17549053
[TBL] [Abstract] [Full Text] [Related]
19. Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma.
Shin SW; Do YS; Choo SW; Lieu WC; Cho SK; Park KB; Yoo BC; Kang EH; Choo IW
Radiology; 2006 Nov; 241(2):581-8. PubMed ID: 17005772
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a novel member of the snail/Gfi-1 repressor family, mlt 1, which is methylated and silenced in liver tumors of SV40 T antigen transgenic mice.
Tateno M; Fukunishi Y; Komatsu S; Okazaki Y; Kawai J; Shibata K; Itoh M; Muramatsu M; Held WA; Hayashizaki Y
Cancer Res; 2001 Feb; 61(3):1144-53. PubMed ID: 11221845
[TBL] [Abstract] [Full Text] [Related]
